PCA safety data review after clinical decision support and smart pump technology implementation.

Area of Science:

• Medical Informatics
• Patient Safety
• Pharmacology

Background:

• Medication errors constitute 20% of U.S. medical errors, with prescribing and administration posing the highest risks.
• Opioid analgesics, frequently used for pain management, can lead to patient harm if not prescribed or administered correctly.
• Duke University Hospital implemented clinical decision support (CDS) using CPOE and smart pumps in February 2008 to mitigate patient-controlled analgesia (PCA) adverse events.

Purpose of the Study:

• To evaluate the impact of CDS technology on PCA safety events.
• To assess the reduction in adverse drug events (ADEs) related to opioid therapy in adult patients requiring analgesia.
• To compare PCA safety pre- and post-implementation of CPOE and smart pump technology.

Main Methods:

• A retrospective analysis of PCA safety events was conducted.
• Data were collected from voluntary report systems and adverse drug events via surveillance (ADE-S).
• Intermediate and step-down units were included, comparing pre- and post-implementation periods of CDS.

Main Results:

• Adverse drug events via surveillance (ADE-S) PCA events per 1000 PCA days decreased by 22% (5.3 to 4.2, P=0.09).
• Voluntary report system PCA events decreased by 72% (2.4 to 0.66 per 1000 PCA days, P < 0.001).
• Causality in ADE-S data showed statistical significance (P < 0.0001), with sleep apnea and renal insufficiency approaching significance; obesity and weight were significant for voluntary reports.

Conclusions:

• The study demonstrated a significant decrease in PCA events following the implementation of CDS.
• Both ADE-S and voluntary reporting systems indicated improved patient safety.
• Clinical decision support via CPOE and PCA smart pump technology is recommended for enhancing opioid safety.